BREAST ATYPICAL LOBULAR HYPERPLASIA
Clinical trials for BREAST ATYPICAL LOBULAR HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BREAST ATYPICAL LOBULAR HYPERPLASIA trials appear
Sign up with your email to follow new studies for BREAST ATYPICAL LOBULAR HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized pill dose could sharply cut breast cancer risk
Prevention Recruiting nowThis study is testing a personalized approach to using the drug tamoxifen to prevent breast cancer in premenopausal women at higher-than-average risk. Researchers want to see if starting with a low dose and increasing it only for women who don't show a good initial response on th…
Matched conditions: BREAST ATYPICAL LOBULAR HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
Personalized genetics could transform breast cancer prevention for minority women
Knowledge-focused Recruiting nowThis study aims to see if adding a genetic risk score to standard breast cancer risk assessments helps African American and Hispanic women make more informed decisions about screening and prevention. Researchers will follow 50 women with elevated breast cancer risk for 10 years t…
Matched conditions: BREAST ATYPICAL LOBULAR HYPERPLASIA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC